“outpatient IV remdesivir”
I thought remdesivir has been proven ineffective in many studies and causes serious kidney damage.
They switched the labels in the study and put Ivermectin in place of Remdesivir
Remdesivir is a pure antiviral. Given to patients with respiratory failure, it has a very small effect, because for most of them the virus part of the disease is over.
A recent large study of 3 days of remdesivir once a day for outpatients with risk factors for progression showed an 86% decrease in hospitalizations compared to a control group.